Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Prepaid Assets (2016 - 2026)

Agios Pharmaceuticals (AGIO) has disclosed Prepaid Assets for 15 consecutive years, with $46.6 million as the latest value for Q1 2026.

  • For Q1 2026, Prepaid Assets rose 10.15% year-over-year to $46.6 million; the TTM value through Mar 2026 reached $46.6 million, up 10.15%, while the annual FY2025 figure was $44.1 million, 9.87% up from the prior year.
  • Prepaid Assets hit $46.6 million in Q1 2026 for Agios Pharmaceuticals, up from $44.1 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $46.6 million in Q1 2026 and bottomed at $34.5 million in Q2 2024.
  • Average Prepaid Assets over 5 years is $40.9 million, with a median of $40.2 million recorded in 2024.
  • Year-over-year, Prepaid Assets skyrocketed 121.55% in 2022 and then fell 17.37% in 2023.
  • Agios Pharmaceuticals' Prepaid Assets stood at $39.0 million in 2022, then decreased by 10.1% to $35.0 million in 2023, then grew by 14.69% to $40.2 million in 2024, then increased by 9.87% to $44.1 million in 2025, then increased by 5.57% to $46.6 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $46.6 million, $44.1 million, and $43.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.